Digital Pathology Market Size At US$2,045.9 Million


Pune, India, September 19, 2022 (GLOBE NEWSWIRE) – Global digital pathology market The market size was valued at $798.8 Million in 2021 and touched $892.5 Million in 2022. The market is expected to reach $2,045.9 Million by 2029, registering a CAGR of 12.6% during the forecast period. Increased awareness of new diagnoses and the increased prevalence of chronic disorders are likely to spur market growth. Fortune Business Insights™ shares this information in its report titled “Digital Pathology Market, 2022-2029”.

Major industry development

  • March 2022 – Thermo Fisher Scientific, Inc. The CE-IVD-branded Ion Torrent Genexus Dx Integrated Sequencer is a next-generation automated sequencing (NGS) platform for use in clinical laboratories and for both diagnostic and clinical research.
  • April 2022- 3DHISTECH Ltd. has entered into Agreement with the Catalan Health Institute (ICS). This strategy was implemented to disseminate digital pathology tools within a network of 8 hospitals.

Get a sample brochure PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digital-pathology-market-100229

Report coverage

The report provides a detailed analysis of the most important sectors and the latest trends in the market. It comprehensively discusses the driving factors, limiting factors and the impact of COVID-19 on the market. In addition, it studies regional developments and the strategies pursued by the major players in the market.

Scope of the report:

Report coverage details
prediction period 2022 to 2029
Forecast period from 2022 to 2029 CAGR 12.6%
2029 Value Drop 2,045.9 million
base year 2021
Market size in 2022 892.5 million US dollars
Historical data about 2018 to 2020
number of pages 149

driving factors

Strong approvals for digital tools may boost market growth

Digital pathology is a digital tool that collects, analyzes and interprets pathological information. The increasing approvals of digital tools may boost the demand for the product. The rise in chronic disorders and the adoption of accelerated procedures may boost the adoption of services. Moreover, the increasing applications of the service have boosted the growth of the industry. Also, strong demand for drug discovery using high-throughput applications may boost product adoption. In addition, the introduction of digital pathology may increase the demand for services. These factors may drive the growth of the digital pathology market.

However, the high installation costs offered for the services may hinder the progress of the market.

Click here for the short- and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/digital-pathology-market-100229

fragmentation

The device segment may retain a dominant market share due to the strong demand for time-saving pathology results

By product, the market is segmented into hardware, software, and storage systems.

The hardware sector may dominate due to the strong demand for time-saving pathology results. Moreover, companies place great emphasis on satisfying the demand for pathology and diagnostics, thus raising the advancement of the market.

Drug discovery part dominates due to strong demand for potential pipeline drugs

Based on the application, the market is segmented into disease diagnosis, drug discovery, and others.

The drug discovery segment may dominate the market share due to the strong adoption of potential pipeline drugs. Moreover, increased awareness regarding preventive pathology may drive sectoral growth.

Hospitals and clinics sector dominates the market share due to the strong acceptance of hospitals

According to the end user, the market is categorized into hospitals, clinics, clinical laboratories, and others.

The Hospitals and Clinics segment is expected to dominate the market share due to the rise in hospital admissions. Also, strategic cooperation to launch advanced products may enhance market progress.

Geographically, the market overlaps with North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

digital pathology market fragmentation Secondary

  • Scanners
  • tissue microarray
  • Aharon
  • Pathology Department
  • digital microscope viewers
  • Image Analyzers
  • Aharon
According to the application

  • disease diagnosis
  • real estate discovery
  • Aharon
by end user

  • Hospitals and clinics
  • Clinical laboratories
  • Aharon

Quick Buy – Digital Pathology Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100229

The impact of COVID-19:

Strong demand for healthcare devices has boosted market progress

This industry has been positively impacted during the COVID-19 pandemic due to the strong demand for healthcare devices. The increase in cases of chronic disorders has increased the demand for pathology instruments, thus boosting sales. Moreover, an increase in government initiatives promoting adoption of virtual coronavirus treatment procedures has improved product adoption. Furthermore, the expansion of virtual education has made it possible for healthcare practitioners to assist patients using virtual means. For example, the Centers for Medicare and Medicaid Services (CMS) announced organizational changes to transform medical services. It allowed patients in the United States to obtain effective medical treatment. These factors drove the industry’s growth during the pandemic.

Regional Insights

Increasing elderly population may boost industry growth in North America

North America is expected to dominate the digital pathology market share due to the rising number of elderly people. The North American market reached US$280.6 million in 2021 and is likely to grow positively in the coming years. Moreover, strong demand for workload simplification may lead to further market growth.

In Europe, consumers’ growing preference for digital tools has led to an increased demand for digital pathology. Moreover, increased adoption of technologically advanced products is likely to boost market growth.

In the Asia Pacific region, increased partnerships between healthcare companies and chains may boost the adoption of virtual pathology services. Moreover, strong investments in private and public enterprises may boost the growth of the industry.

Competitive scene

Key players cooperate with major players to expand market presence

Prominent companies operating in the market cooperate with key players to expand their presence in the market. For example, Leica Biosystems Nussloch GmbH entered into a partnership with Leap Therapeutics in January 2022. This development was aimed at developing diagnostics for Dickkop-associated protein 1 (DKK1) and anti-DKK1 cancer therapy from Leap Therapeutics. This strategy may also allow the company to expand its presence in the market. Further, companies innovate mergers, expansions, new product launches, research and development, and innovations to strengthen their market position.

Do you have any questions? Ask our experts: https://www.fortunebusinessinsights.com/enquiry/queries/digital-pathology-market-100229

List of the main players in the file digital pathology market a report:

  • Thermo Fisher Scientific Inc. (United State)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Hamamatsu Photonics KK (Japan)
  • 3DHISTECH Ltd. (Hungary)
  • Koninklijke Philips NV (Netherlands)
  • Apollo Enterprise Imaging Corp (US)
  • Sectra AB (Sweden)
  • Huron Technologies International Inc. (Canada)

content list

  • an introduction
    • Search scope
    • Market segmentation
    • Research Methodology
  • Executive Summary
  • market dynamics
    • Market Drivers
    • market restrictions
    • Market Opportunities
  • the main ideas
    • Key Industry Developments – Mergers, Acquisitions and Partnerships
    • Technological advances in digital pathology
    • Snapshot: The global digital health market, 2021
    • Impact of COVID-19 on the market
  • Global Digital Diseases Market Analysis, Insights And Forecast, 2018-2029
    • Market Analysis, Insights and Forecasts – By Product
        • Scanners
        • tissue microarray
        • Aharon
        • Pathology Department
        • digital microscope viewers
        • Image Analyzers
        • Aharon
  • North America Digital Disease Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecasts – By Product
    • Market analysis, insights and forecasts – by application
      • disease diagnosis
      • real estate discovery
      • Aharon
    • Market analysis, insights and forecasts – by the end user
      • Hospitals and clinics
      • Clinical laboratories
      • Aharon
    • Market Analysis, Insights and Forecasts – By Region
      • North Amarica
      • Europe
      • Asia Pacific
      • Latin america
      • Middle East and Africa
        • Scanners
        • tissue microarray
        • Aharon
        • Pathology Department
        • digital microscope viewers
        • Image Analyzers
        • Aharon
  • Europe Digital Pathology Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecasts – By Product
    • Market analysis, insights and forecasts – by application
      • disease diagnosis
      • real estate discovery
      • Aharon
    • Market analysis, insights and forecasts – by the end user
      • Hospitals and clinics
      • Clinical laboratories
      • Aharon
    • Market Analysis, Insights and Forecasts – By Country
        • Scanners
        • tissue microarray
        • Aharon
  • Asia Pacific Digital Diseases Market Analysis, Insights & Forecast, 2018-2029
  • Latin America Digital Disease Market Analysis, Insights and Forecast, 2018-2029
  • Middle East and Africa Digital Diseases Market Analysis, Insights and Forecast, 2018-2029
  • competitive analysis
    • Market analysis, insights and forecasts – by application
      • disease diagnosis
      • real estate discovery
      • Aharon
    • Market analysis, insights and forecasts – by the end user
      • Hospitals and clinics
      • Clinical laboratories
      • Aharon
    • Market analysis, insights and forecasts – by country/sub-region
    • Global Market Share Analysis (2021)
    • Company profiles (overview, products, SWOT analysis, recent developments, strategies, financial statements (based on availability))
      • Leica Biosystems Nussloch GmbH
      • Thermo Fisher Scientific Inc.
      • F. Hoffmann-La Roche Ltd
      • Hamamatsu Photonics KK
      • Akoya Biosciences, Inc.
      • 3DHISTECH Ltd.
      • Koninklijke Philips NV
      • Apollo Enterprise Imaging Corp
      • sectra AB
      • Huron Technologies International Inc.

Get your own custom search report: https://www.fortunebusinessinsights.com/enquiry/customization/digital-pathology-market-100229

information about us:

Fortune Business Insights™ delivers accurate data and innovative analytics for businesses, helping organizations of all sizes make the right decisions. We design new solutions for our clients, and help them tackle the different challenges that characterize their business. Our goal is to empower them with comprehensive market intelligence, and to provide an accurate overview of the market in which they operate.

call us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower,

Baneer – Mahalung Road,

Banner, Pune-411045,

Maharashtra, India.

phone:

United States: +1 424253 0390

United Kingdom: +44 2071 939123

Asia Pacific: +91744740 1245


Leave a Reply

Your email address will not be published. Required fields are marked *